US · Healthcare · Medical Instruments & Supplies
EPS came in at -0.64 against a street estimate of -0.70 — a beat of 8.6%.
Analysts rate Bionano Genomics Inc a strong buy (2 buy, 0 hold, 0 sell out of 2) with an average price target of $5.00.
| Fund | Stake |
|---|---|
| GSA Capital Partners LLP | 1.28% |
| Carret & Company Inc | 1.06% |
| Geode Capital Management, LLC | 0.76% |
| Vanguard Capital Management, LLC | 0.70% |
| Vanguard Fiduciary Trust Co | 0.44% |
| Renaissance Technologies Corp | 0.43% |
| Jane Street Group LLC | 0.30% |
| Prudential Financial Inc | 0.27% |
Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Bionano Genomics Inc — free to start.
Open in the appGoogle PlayApp StoreData updated 2026-10-18.